Jim Cramer highlights that today's stock market is punishing companies that miss expectations more aggressively than during the 1999 dot-com bubble. While the S&P 500 and Nasdaq hit record highs, the market is narrowly focused on artificial intelligence winners, severely selling off other sectors like healthcare and medical technology. Stocks such as Abbott Laboratories and Danaher have dropped sharply despite their strong histories. Cramer warns that this bifurcation shows extreme investor behavior, with some stocks overly loved and others excessively hated, making the current market dynamics more intense than the dot-com era.
The global blood glucose monitoring system market, valued at $16.8 billion in 2025, is projected to grow to $39.4 billion by 2035 at an 8.9% CAGR. Growth is fueled by rising diabetes prevalence, advancements in AI-enabled monitoring devices, and incr...
The veterinary lab automation market is projected to grow from $1.36 billion in 2026 to $1.9 billion by 2030, with a CAGR of 8.7%. Growth is fueled by rising demand for rapid diagnostics, AI integration, and precision veterinary medicine, alongside i...
The veterinary lab automation market is projected to grow from $1.36 billion in 2026 to $1.9 billion by 2030, with a CAGR of 8.7%. Growth is fueled by increasing demand for rapid diagnostics, AI integration, robotic workflows, and a focus on companio...
